ArticleInternational journal of molecular sciences2019

In Vivo Glycan Engineering via the Mannosidase I Inhibitor (Kifunensine) Improves Efficacy of Rituximab Manufactured in

Vally Kommineni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.